Affiliation:
1. Department of Epidemiology, Laboratories and Research
2. OPS/OMS
3. National Laboratory of Public Health
Abstract
Abstract
Background
Healthcare workers are an exposed group for SARS-CoV-2 and this exposure is a public health priority. Transmission can occur from infected patients to staff and from infected staff to patients and co-workers, thus undermining the health care system. This study estimated the seroprevalence in this population and identified some associated factors.
Methods
We analyzed the exposure of healthcare workers in ten (10) large hospitals providing care to patients with covid-19 by testing for antibodies to SARS-CoV-2. Potential risk factors such as age, vaccination history, barrier measures such as masking were explored through a questionnaire.
Results
From December 06 to 15, 2021, among 3743 health care workers in major hospitals providing care to patients with covid19, a sample of 566 had received serological testing for SARS-COV-2. The mean age was 39 years, 62% were female, and about 12% had hypertension. The vast majority did not reveal any signs and symptoms compatible with COVID19, 62% had already received anti-covid19 vaccine.
The national prevalence regardless of vaccination status was 44%, with a predominance of male gender, age group 60 and older, and the Western Department. Prevalence among unvaccinated persons was 11.59% and never wearing masks was an increased risk of developing antibodies to SARS-COV2.
Conclusion
Among health care workers, covid-19 affects both sexes with a female predominance. The age group over 60 years is the most affected and not wearing a mask is a risk factor associated with virus detection.
Publisher
Research Square Platform LLC
Reference21 articles.
1. Organisation mondiale de la Santé. Protocole d’enquête séroépidémiologique sur l’infection par le virus de la COVID-19 par tranche d’âge dans la population, 17 mars 2020 [Internet]. Organisation mondiale de la Santé; 2020 [cited 2022 Apr 26]. Report No.: WHO/2019-nCoV/Seroepidemiology/2020.1. Available from: https://apps.who.int/iris/handle/10665/331526.
2. COVID-19 étude population (SEROCoV-POP). - Etude de l’Unité d’épidémiologie populationnelle (UEP) | HUG - Hôpitaux Universitaires de Genève [Internet]. [cited 2022 Apr 26]. Available from: https://www.hug.ch/medecine-premier-recours/covid-19-etude-population-serocov-pop.
3. Coronavirus disease (COVID-19). : Serology, antibodies and immunity [Internet]. [cited 2022 Apr 26]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-serology.
4. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic;Venugopal U;Int J Infect Dis,2021
5. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020;Bajema KL;JAMA Intern Med,2021